Dr. Bilal H. Naqvi
Claim this profileMarshfield Clinic-Minocqua Center
Area of expertise
Oropharyngeal Carcinoma
Bilal H. Naqvi has run 2 trials for Oropharyngeal Carcinoma. Some of their research focus areas include:
Fallopian Tube Carcinoma
Bilal H. Naqvi has run 2 trials for Fallopian Tube Carcinoma. Some of their research focus areas include:
Affiliated Hospitals
Marshfield Clinic-Minocqua Center
Marshfield Medical Center-EC Cancer Center
Clinical Trials Bilal H. Naqvi is currently running
Duvelisib/CC-486 + Chemotherapy
for Lymphoma
This phase II trial studies the effect of duvelisib or CC-486 and usual chemotherapy consisting of cyclophosphamide, doxorubicin, vincristine, etoposide, and prednisone in treating patients with peripheral T-cell lymphoma. Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, doxorubicin, vincristine, etoposide and prednisone, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial may help find out if this approach is better or worse than the usual approach for treating peripheral T-cell lymphoma.
Recruiting
1 award
Phase 2
27 criteria
Cabozantinib + Nivolumab
for Advanced Skin and Head & Neck Cancers
This phase II trial studies the good and bad effects of the combination of drugs called cabozantinib and nivolumab in treating patients with melanoma or squamous cell head and neck cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help doctors determine how quickly patients can be divided into groups based on biomarkers in their tumors. A biomarker is a biological molecule found in the blood, other body fluids, or in tissues that is a sign of a normal or abnormal process or a sign of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. The two biomarkers that this trial is studying are "tumor mutational burden" and "tumor inflammation signature." Another purpose of this trial is to help doctors learn if cabozantinib and nivolumab shrink or stabilize the cancer, and whether patients respond differently to the combination depending on the status of the biomarkers.
Recruiting
1 award
Phase 2
More about Bilal H. Naqvi
Clinical Trial Related
6 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Bilal H. Naqvi has experience with
- Cyclophosphamide
- Prednisone
- Cisplatin
- Durvalumab
- Bendamustine Hydrochloride
- Lenalidomide
Breakdown of trials Bilal H. Naqvi has run
Oropharyngeal Carcinoma
Fallopian Tube Carcinoma
Oropharyngeal Cancer
Skin Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Bilal H. Naqvi specialize in?
Bilal H. Naqvi focuses on Oropharyngeal Carcinoma and Fallopian Tube Carcinoma. In particular, much of their work with Oropharyngeal Carcinoma has involved p16 positive patients, or patients who are Stage IV.
Is Bilal H. Naqvi currently recruiting for clinical trials?
Yes, Bilal H. Naqvi is currently recruiting for 2 clinical trials in Minocqua Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Bilal H. Naqvi has studied deeply?
Yes, Bilal H. Naqvi has studied treatments such as Cyclophosphamide, Prednisone, Cisplatin.
What is the best way to schedule an appointment with Bilal H. Naqvi?
Apply for one of the trials that Bilal H. Naqvi is conducting.
What is the office address of Bilal H. Naqvi?
The office of Bilal H. Naqvi is located at: Marshfield Clinic-Minocqua Center, Minocqua, Wisconsin 54548 United States. This is the address for their practice at the Marshfield Clinic-Minocqua Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.